Welcure Drugs & Pharmaceuticals has informed about Statement of Investor complaint duly signed by Authorized Signatory of Registrar and share transfer Agent and Company Secretary of the Company for the quarter ended on 30.09.2017.
The above information is a part of company’s filings submitted to BSE.